Literature DB >> 1724156

alpha 2-Macroglobulin is cleaved by HIV-1 protease in the bait region but not in the C-terminal inter-domain region.

U C Meier1, A Billich, K Mann, H J Schramm, W Schramm.   

Abstract

alpha 2-Macroglobulin is cleaved by human immunodeficiency virus-1 protease. The cleavage site is the Phe684-Tyr685 bond in the "bait region", an exposed part of alpha 2-macroglobulin, creating the "F-form". The methylamine derivative of alpha 2-macroglobulin is also cleaved at the same bond. The homologous chicken ovomacroglobulin does not form an F-form structure with the protease, although, F-form generation by other enzymes is known. This is possibly due to the lack of a suitable cleavage sequence in the corresponding region of ovomacroglobulin. In human alpha 2-macroglobulin, the interdomain segment between the main part of the molecule and the receptor-binding C-terminal domain is not cleaved by the HIV protease although typical cleavage sequences occur. In AIDS, therefore, HIV protease from infected cells in unlikely to interfere with receptor-binding of alpha 2-macroglobulin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1724156     DOI: 10.1515/bchm3.1991.372.2.1051

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  3 in total

1.  Identification of the nephropathy-susceptibility locus HIVAN4.

Authors:  Sindhuri Prakash; Natalia Papeta; Roel Sterken; Zongyu Zheng; Robert L Thomas; Zhenzhen Wu; John R Sedor; Vivette D D'Agati; Leslie A Bruggeman; Ali G Gharavi
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

2.  COVID-19 Salivary Protein Profile: Unravelling Molecular Aspects of SARS-CoV-2 Infection.

Authors:  Eduardo Esteves; Vera M Mendes; Bruno Manadas; Rafaela Lopes; Liliana Bernardino; Maria José Correia; Marlene Barros; Ana Cristina Esteves; Nuno Rosa
Journal:  J Clin Med       Date:  2022-09-22       Impact factor: 4.964

3.  Thromboinflammation in COVID-19: Can α2 -macroglobulin help to control the fire?

Authors:  Rainer Seitz; Lutz Gürtler; Wolfgang Schramm
Journal:  J Thromb Haemost       Date:  2020-12-19       Impact factor: 16.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.